Article
A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo.
The Journal of investigative dermatology - 1 Jan 2014
Lister James A, Capper Amy, Zeng Zhiqiang, Mathers Marie E, Richardson Jennifer, Paranthaman Karthika, Jackson Ian J, Elizabeth Patton E
Abstract excerpt
The microphthalmia-associated transcription factor (MITF) is the "master melanocyte transcription factor" with a complex role in melanoma. MITF protein levels vary between and within clinical specimens, and amplifications and gain- and loss-of-function mutations have been identified in melanoma. How MITF functions in melanoma development and the effects of targeting MITF in vivo are unknown because MITF levels...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
